These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6614100)

  • 21. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay.
    Matsuo K; Bond VK; Im DD; Rosenshein NB
    Am J Clin Oncol; 2010 Aug; 33(4):358-63. PubMed ID: 19875949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z; Pásti G; Lampé L; Juhász B
    Zentralbl Gynakol; 1985; 107(17):1065-71. PubMed ID: 4060913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The true predictive value of the human tumor stem cell assay: does a workable assay select for treatment responders?
    Hug V; Thames H; Johnston D; Blumenschein G; Drewinko B; Spitzer G
    J Clin Oncol; 1984 Jan; 2(1):42-5. PubMed ID: 6699657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
    Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentials and drawbacks of the human tumor stem cell assay.
    Shoemaker RH; Wolpert-DeFilippes MK; Venditti JM
    Behring Inst Mitt; 1984 May; (74):262-72. PubMed ID: 6477356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity test for anti-tumor agents-3. MTT assay and its clinical effect].
    Wada Y; Tomiyoshi Y; Fujimaru J; Ogura M; Hirabayashi K; Yoshida S; Takeda Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2349-54. PubMed ID: 1463341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
    Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro assay for sensitivity to anticancer drugs.
    Salmon SE
    Hosp Pract (Off Ed); 1985 Jun; 20(6):133-7, 141-2, 145-8. PubMed ID: 3924923
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical correlations of drug sensitivity in the human tumor stem cell assay.
    Salmon SE; Alberts DS; Durie BG; Meyskens FL; Jones SE; Soehnlen B; Chen HS; Moon T
    Recent Results Cancer Res; 1980; 74():300-5. PubMed ID: 7444146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
    Ng TY; Ngan HY; Cheng DK; Wong LC
    Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer.
    Kimble DC; Dvergsten E; Thomeas-McEwing V; Karovic S; Conrads TP; Maitland ML
    Gynecol Oncol; 2021 Jan; 160(1):295-301. PubMed ID: 33190933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human colorectal carcinoma: patterns of sensitivity to chemotherapeutic agents in the human tumor stem cell assay.
    Agrez MV; Kovach JS; Beart RW; Rubin J; Moertel CG; Lieber MM
    J Surg Oncol; 1982 Jul; 20(3):187-91. PubMed ID: 7087490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.
    Alberts DS; Samon SE; Chen HS; Surwit EA; Soehnlen B; Young L; Moon TE
    Lancet; 1980 Aug; 2(8190):340-2. PubMed ID: 6105478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(1-2):1-12. PubMed ID: 7226159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heterogeneity in drug sensitivity of human tumors in the human tumor colony-forming assay].
    Tanigawa N; Mizuno Y; Honda K; Hashimura T; Satomura K; Hikasa Y
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):800-803. PubMed ID: 6676649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
    Bénard J; Riou G
    Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro chemosensitivity of lung cancer and other chest tumors evaluated by human tumor colony assay].
    Lee K; Kuze F; Hashimura T; Tanigawa N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2537-43. PubMed ID: 6095761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.